These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25946293)

  • 21. The Angiotensin-Converting-Enzyme-Induced Angioedema.
    Bas M
    Immunol Allergy Clin North Am; 2017 Feb; 37(1):183-200. PubMed ID: 27886906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Angiotensin-converting enzyme inhibitor induced angioedema : new therapy options].
    Bas M; Kojda G; Stelter K
    Anaesthesist; 2011 Dec; 60(12):1141-5. PubMed ID: 20922352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Bradykinin Receptor Blockade During Hemorrhagic Shock in Mice Prevents the Worsening Hypotensive Effect of Angiotensin-Converting Enzyme Inhibitor.
    Charbonneau H; Buléon M; Minville V; Faguer S; Girolami JP; Bascands JL; Tack I; Mayeur N
    Crit Care Med; 2016 Sep; 44(9):e882-5. PubMed ID: 26992065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MDMA-induced angioedema treated with icatibant.
    Supervía A; Del Baño F
    Clin Toxicol (Phila); 2016 Mar; 54(3):294. PubMed ID: 26857700
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin].
    Muller Y; Harr T
    Rev Med Suisse; 2016 Jan; 12(500):11-2. PubMed ID: 26946694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter in response to "MDMA-induced angioedema treated with icatibant".
    Wilkerson RG; Hayes BD
    Clin Toxicol (Phila); 2016 Mar; 54(3):293. PubMed ID: 26817391
    [No Abstract]   [Full Text] [Related]  

  • 27. Bradykinin-receptor antagonist icatibant: possible treatment for ACE inhibitor-related angio-oedema.
    Manders K; van Deuren M; Hoedemaekers C; Simon A
    Neth J Med; 2012 Oct; 70(8):386-7. PubMed ID: 23065991
    [No Abstract]   [Full Text] [Related]  

  • 28. ACE inhibitor-induced angioedema.
    Baram M; Kommuri A; Sellers SA; Cohn JR
    J Allergy Clin Immunol Pract; 2013; 1(5):442-5. PubMed ID: 24565614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review.
    Lawlor CM; Ananth A; Barton BM; Flowers TC; McCoul ED
    Otolaryngol Head Neck Surg; 2018 Feb; 158(2):232-239. PubMed ID: 29112487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Icatibant as a Potential Treatment of Life-Threatening Alteplase-Induced Angioedema.
    Cheong E; Dodd L; Smith W; Kleinig T
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):e36-e37. PubMed ID: 29097062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDMA-induced angioedema treated with icatibant.
    Escalante FA; Del Baño F; Supervía A
    Clin Toxicol (Phila); 2015; 53(10):1148-9. PubMed ID: 26479353
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of angiotensin receptor blocker-induced angioedema: A case series.
    Strassen U; Bas M; Hoffmann TK; Knopf A; Greve J
    Laryngoscope; 2015 Jul; 125(7):1619-23. PubMed ID: 25646708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Icatibant Compared to Steroids and Antihistamines for ACE-Inhibitor-Induced Angioedema.
    Botnaru T; Robert A; Mottillo S
    CJEM; 2017 Mar; 19(2):159-162. PubMed ID: 27189625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
    Bas M; Greve J; Stelter K; Bier H; Stark T; Hoffmann TK; Kojda G
    Ann Emerg Med; 2010 Sep; 56(3):278-82. PubMed ID: 20447725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular and Diabetic Medications That Cause Bradykinin-Mediated Angioedema.
    Hudey SN; Westermann-Clark E; Lockey RF
    J Allergy Clin Immunol Pract; 2017; 5(3):610-615. PubMed ID: 28483314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors.
    Gallitelli M; Alzetta M
    Am J Emerg Med; 2012 Oct; 30(8):1664.e1-2. PubMed ID: 22100478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACE inhibitor-mediated angioedema.
    Montinaro V; Cicardi M
    Int Immunopharmacol; 2020 Jan; 78():106081. PubMed ID: 31835086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Life-threatening ACE inhibitor-induced angio-oedema successfully treated with icatibant: a bradykinin receptor antagonist.
    Ostenfeld S; Bygum A; Rasmussen ER
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26498671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: A meta-analysis of randomized controlled trials.
    Jeon J; Lee YJ; Lee SY
    J Clin Pharm Ther; 2019 Oct; 44(5):685-692. PubMed ID: 31290163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with icatibant in the management of drug induced angioedema.
    Bertazzoni G; Bresciani E; Cipollone L; Fante E; Galandrini R
    Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):149-53. PubMed ID: 25635988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.